Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Asai

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The Annals of Pharmacotherapy|June 6, 2024
Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control StudyHayahide Ooi, Yuki Asai, Yoshiki Koriyama, et al.
Journal of Clinical Pharmacology|August 7, 2022
Exploratory Study of Pharmacists' Monitoring Methods Based on Left Ventricular Function for Hypermagnesemia by Magnesium Oxide in Heart FailureYuki Asai, Tatsuki Yanagawa, Takanori Yamamoto, et al.
Journal of Pharmaceutical Health Care and Sciences|April 24, 2025
Diagnostic assistance provided by a pharmacist for the syndrome of inappropriate antidiuretic hormone secretion caused by carboplatin plus nab-paclitaxel chemotherapy in an elderly patient with lung cancer: a case reportHayahide Ooi, Yuki Asai, Yasumasa Sakakura, et al.
Cancer Reports (Hoboken, N.J.)|January 20, 2026
Clinical Course and Risk Factors of Lenvatinib-Related Hypothyroidism in Hepatocellular Carcinoma: A Retrospective Cohort StudyChihiro Shiraishi, Hideo Kato, Yuki Asai, et al.
Biological & Pharmaceutical Bulletin|December 3, 2023
Effect of Ceftriaxone Dosage and Albumin-Bilirubin Score on the Risk of Ceftriaxone-Induced Liver InjuryHayahide Ooi, Yuki Asai, Yoshiki Koriyama, et al.
Biopharmaceutics & Drug Disposition|November 14, 2017
Effect of status epilepticus on expression of brain UDP-glucuronosyltransferase 1a in ratsYuki Asai, Hatsuna Tanaka, Masayuki Nadai, et al.
Journal of Pharmaceutical Sciences|November 28, 2017
Status Epilepticus Decreases Brain Cytochrome P450 2D4 Expression in RatsYuki Asai, Hatsuna Tanaka, Masayuki Nadai, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 31, 2022
[Evaluation of Disopyramide Efficacy for Refractory Syncope in Heart Failure with Preserved Ejection Fraction Using Holter Electrocardiography: A Case Report]Yuki Asai, Takuya Shintani, Takanori Yamamoto, et al.
Biological & Pharmaceutical Bulletin|June 17, 2026
A Single-Institution, Exploratory, Retrospective Observational Study on Nausea during Cabozantinib Administration with Antiemetic TherapySaori Inagaki, Yusuke Nakatani, Yuki Asai, et al.
Biological & Pharmaceutical Bulletin|April 1, 2026
Evaluation of the Perceptions and Acceptability of Checklist for Assessing Achievement in Hospital Practical Training for Pharmacy School Students: A Prospective Questionnaire-Based SurveyYuki Asai, Hideo Kato, Shun-Ichi Hiramatsu, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The Annals of Pharmacotherapy|June 6, 2024
Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control StudyHayahide Ooi, Yuki Asai, Yoshiki Koriyama, et al.
Journal of Clinical Pharmacology|August 7, 2022
Exploratory Study of Pharmacists' Monitoring Methods Based on Left Ventricular Function for Hypermagnesemia by Magnesium Oxide in Heart FailureYuki Asai, Tatsuki Yanagawa, Takanori Yamamoto, et al.
Journal of Pharmaceutical Health Care and Sciences|April 24, 2025
Diagnostic assistance provided by a pharmacist for the syndrome of inappropriate antidiuretic hormone secretion caused by carboplatin plus nab-paclitaxel chemotherapy in an elderly patient with lung cancer: a case reportHayahide Ooi, Yuki Asai, Yasumasa Sakakura, et al.
Cancer Reports (Hoboken, N.J.)|January 20, 2026
Clinical Course and Risk Factors of Lenvatinib-Related Hypothyroidism in Hepatocellular Carcinoma: A Retrospective Cohort StudyChihiro Shiraishi, Hideo Kato, Yuki Asai, et al.
Biological & Pharmaceutical Bulletin|December 3, 2023
Effect of Ceftriaxone Dosage and Albumin-Bilirubin Score on the Risk of Ceftriaxone-Induced Liver InjuryHayahide Ooi, Yuki Asai, Yoshiki Koriyama, et al.
Biopharmaceutics & Drug Disposition|November 14, 2017
Effect of status epilepticus on expression of brain UDP-glucuronosyltransferase 1a in ratsYuki Asai, Hatsuna Tanaka, Masayuki Nadai, et al.
Journal of Pharmaceutical Sciences|November 28, 2017
Status Epilepticus Decreases Brain Cytochrome P450 2D4 Expression in RatsYuki Asai, Hatsuna Tanaka, Masayuki Nadai, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 31, 2022
[Evaluation of Disopyramide Efficacy for Refractory Syncope in Heart Failure with Preserved Ejection Fraction Using Holter Electrocardiography: A Case Report]Yuki Asai, Takuya Shintani, Takanori Yamamoto, et al.
Biological & Pharmaceutical Bulletin|June 17, 2026
A Single-Institution, Exploratory, Retrospective Observational Study on Nausea during Cabozantinib Administration with Antiemetic TherapySaori Inagaki, Yusuke Nakatani, Yuki Asai, et al.
Biological & Pharmaceutical Bulletin|April 1, 2026
Evaluation of the Perceptions and Acceptability of Checklist for Assessing Achievement in Hospital Practical Training for Pharmacy School Students: A Prospective Questionnaire-Based SurveyYuki Asai, Hideo Kato, Shun-Ichi Hiramatsu, et al.
Pageof 6